← Leaderboards
Enid R Neptune
Johns Hopkins University
$11,248,461
Attributed
$12,898,126
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,898,126 · 8
By mechanism
R01$11,100,768 · 5
P50$976,508 · 1
K08$656,850 · 1
R03$164,000 · 1
Top collaborators
- Jung Soo Suk7 shared
- Justin S. Hanes1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- William Brian Dalton$1,023,438
- Amy E Dezern$1,824,012
- Janet T. Holbrook$51,624,279
- Robert A. Wise$33,179,807
- Irina Petrache$14,015,590
Others in their field
Top investigators on “Chronic”
- Judith S. Currier · University Of California Los Angeles$245,012,139
- Lawrence Corey · Fred Hutchinson Cancer Center$209,947,290
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$201,828,077
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$173,476,538
- John M Lachin · George Washington University$125,152,883
- David M Nathan · Massachusetts Institute Of Technology$120,438,756
Research focus
ChronicCigarette SmokeLungLung DiseasesEpithelial CellsLung InjuryPulmonary EmphysemaReceptorApoptosisSignal TransductionChronic Obstructive Airway DiseaseMediatingAttenuatedInflammatoryInjuryCellsAlveolarGeneticCohortCause Of DeathAllelesCigarette Smoke-InducedAdultComplex
Grant awards (31)
Hepatocyte Growth Factor Signaling and Airspace Maintenance$738,663
R01 · FY2024 · HL · contact PI
Hepatocyte Growth Factor Signaling and Airspace Maintenance$755,014
R01 · FY2023 · HL · contact PI
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair$612,340
R01 · FY2023 · HL · contact PI
Hepatocyte Growth Factor Signaling and Airspace Maintenance$744,171
R01 · FY2022 · HL · contact PI
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair$693,753
R01 · FY2022 · HL · contact PI
Hepatocyte Growth Factor Signaling and Airspace Maintenance$759,790
R01 · FY2021 · HL · contact PI
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair$613,110
R01 · FY2021 · HL · contact PI
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair$622,479
R01 · FY2020 · HL · contact PI
New Inhalation Therapy for COPD$409,375
R01 · FY2020 · HL
New Inhalation Therapy for COPD$409,375
R01 · FY2019 · HL
New Inhalation Therapy for COPD$409,323
R01 · FY2018 · HL
Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD$399,855
R01 · FY2018 · HL · contact PI
New Inhalation Therapy for COPD$408,646
R01 · FY2017 · HL
Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD$399,855
R01 · FY2017 · HL · contact PI
Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD$413,485
R01 · FY2016 · HL · contact PI
Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD$449,417
R01 · FY2015 · HL · contact PI
TGFb Modulation: Therapeutic Targeting for COPD-Emphysema$484,510
P50 · FY2012 · HL · contact PI
TGFb Modulation: Therapeutic Targeting for COPD-Emphysema$491,998
P50 · FY2011 · HL · contact PI
The Role of Hepatocyte Growth Factor Signaling Airspace Homeostasis$410,000
R01 · FY2011 · HL · contact PI
The Role of Hepatocyte Growth Factor Signaling Airspace Homeostasis$410,000
R01 · FY2010 · HL · contact PI
The Role of Hepatocyte Growth Factor Signaling Airspace Homeostasis$410,000
R01 · FY2009 · HL · contact PI
The Role of Hepatocyte Growth Factor Signaling Airspace Homeostasis$221,717
R01 · FY2009 · HL · contact PI
Tissue-based validation of COPD Genetic Studies using Lung Health Study Cohort$82,000
R03 · FY2009 · HL · contact PI
The Role of Hepatocyte Growth Factor Signaling Airspace Homeostasis$410,000
R01 · FY2008 · HL · contact PI
Tissue-based validation of COPD Genetic Studies using Lung Health Study Cohort$82,000
R03 · FY2008 · HL · contact PI
The Role of Hepatocyte Growth Factor Signaling Airspace Homeostasis$400,400
R01 · FY2007 · HL · contact PI
Alveolization in Fibrillin-1 Defective Mice$131,490
K08 · FY2005 · HL
Alveolization in Fibrillin-1 Defective Mice$131,490
K08 · FY2004 · HL
Alveolization in Fibrillin-1 Defective Mice$131,490
K08 · FY2003 · HL
Alveolization in Fibrillin-1 Defective Mice$131,490
K08 · FY2002 · HL
Alveolization in Fibrillin-1 Defective Mice$130,890
K08 · FY2001 · HL